Lupus & antiphospholipid syndrome

Utility of the 2019 EULAR/American College of Rheumatology (ACR) systemic lupus erythematosus (SLE) classification criteria for predicting mortality and hospitalisation: development and cross-validation of ominosity score

RMD OpenPublished Population-based cohort study

Main finding · MortalityResult — go to the resultHazard ratio 1.17 95% CI 0.67–2.03

Authors' conclusion

The 2019 EULAR/ACR SLE criteria score was not associated with mortality and hospitalisation. The derived ominosity score for mortality presented good prediction for mortality but was not better than age and sex alone.

Study context

Population
Incident patients with SLE in a population-based cohortincident SLE
Participants
374 patients
Exposure
2019 EULAR/ACR SLE score ≥20 points vs ≤19 points
Outcome
Mortality and hospitalisation
Methodological detailsCox regression adjusted for age, sex and calendar year, LASSO-derived prediction model, cross-validation
  • Cox regression adjusted for age, sex and calendar year
  • LASSO-derived prediction model
  • Cross-validation

Main finding

Mortality

Hazard ratio

1.17

95% CI 0.67–2.03

Score ≥20vs Score ≤19
HR 1.17 (95% CI 0.67–2.03)

As reported in the abstract

Observational data: associations, not effects.

Further findings

OutcomeHR (95% CI)
First hospitalisationAdjusted for age, sex and calendar year1.14 (0.79–1.64)

Ominosity score for mortality (age, sex, thrombocytopaenia, neuropsychiatric manifestations, subacute cutaneous or discoid lupus, non-scarring alopecia, inflammatory arthritis, renal involvement, aPL, hypocomplementaemia): discrimination

Concordance, with adequate calibration
0.76
Concordance of model with age, sex and year only
0.77
  • Age and sex were the main predictors

Original publication

Utility of the 2019 EULAR/ACR SLE classification criteria for predicting mortality and hospitalisation: development and cross-validation of ominosity score. RMD Open. Published 20 November 2024. doi:10.1136/rmdopen-2024-004833

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.